This federal contract award, valued at $1,135.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of the pharmaceutical product "NYMALIZE 60 MG/10 ML SOLUTION 237ML". The contract has a firm fixed price structure and an ultimate completion date of December 3, 2024. This award is not associated with a set-aside designation, indicating open competition. The contract is a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, AmerisourceBergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 2/7/25, 9:18 AM